The EU CRISPR patent landscape: a complex battle In the patent field, CRISPR/Cas technology has sparked intense patent battles in Europe, with significant implications for innovation and market ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

A geneticist, epidemiologist and advocate, Tsosie, Diné, is an accomplished scientist who has made it her mission to bring ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

For its fourth quarter of 2024, CRISPR booked revenue of just under $36 million. That was well under the more than $201 million the company earned in the same period of 2023. On the bottom line, ...

BASF SE, Bayer AG, Syngenta Group, UPL, Corteva, and FMC Corporation Lead the Market Agricultural Microbials Market ...